AIM ImmunoTech (AIM) Current Assets (2010 - 2026)
AIM ImmunoTech's (AIM) quarterly Current Assets came in at $6.2 million in Q1 2026, up 140.48% YoY from $2.6 million in Q1 2025, and up 88.59% on a QoQ basis from $3.3 million in Q4 2025.
AIM ImmunoTech (AIM) Current Assets (2010 - 2026) Analysis & Trends
AIM ImmunoTech (AIM) has 17 years of Current Assets data on file, last reported at $6.2 million in Q1 2026.
- Quarterly Current Assets rose 140.48% year-over-year to $6.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.2 million (up 140.48% YoY) and the FY2025 annual result came in at $3.3 million, down 21.1% from the prior year.
- Current Assets rose to $6.2 million in Q1 2026, from $3.3 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $50.4 million in Q1 2022 to a low of $1.0 million in Q2 2025.
- A 5-year average of $19.0 million and a median of $11.3 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2025 — Current Assets slumped 90.11% — and 2026, when it surged 140.48%.
- Tracing AIM's Current Assets over 5 years: stood at $36.3 million in 2022, then sank by 59.92% to $14.6 million in 2023, then sank by 71.31% to $4.2 million in 2024, then fell by 21.1% to $3.3 million in 2025, then soared by 88.59% to $6.2 million in 2026.
- The last three Current Assets figures came in at $6.2 million (Q1 2026), $3.3 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.88 Bn | 132.03 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.62 Bn | 78.62 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.28 Bn | 60.10 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 61.39 Bn | 56.25 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.37 Bn | 28.06 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.76 Bn | 10.37 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | 1.76 Bn |
| 10 | AIM ImmunoTech | 4.40 Mn | -5.56 Mn | 21,000.00 | 10.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.43 Mn |
| Mar 31, 2026 | 6.21 Mn |
| Dec 31, 2025 | 3.30 Mn |
| Sep 30, 2025 | 2.58 Mn |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 2.58 Mn |
| Dec 31, 2024 | 4.18 Mn |
| Sep 30, 2024 | 7.57 Mn |
| Jun 30, 2024 | 10.36 Mn |
| Mar 31, 2024 | 11.31 Mn |
| Dec 31, 2023 | 14.56 Mn |
| Sep 30, 2023 | 22.74 Mn |
| Jun 30, 2023 | 28.87 Mn |
| Mar 31, 2023 | 33.16 Mn |
| Dec 31, 2022 | 36.32 Mn |
| Sep 30, 2022 | 41.15 Mn |
| Jun 30, 2022 | 46.05 Mn |
| Mar 31, 2022 | 50.38 Mn |
| Dec 31, 2021 | 50.21 Mn |
| Sep 30, 2021 | 38.04 Mn |